Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries

Spasenoska, D; Kahn, A-L; Bouhenia, M; D'Cor, NA; Lee, J-S; Park, SE; Lynch, J

Journal article

Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries

Abstract:: Background
The global resurgence of cholera, a diarrhoeal disease, has resulted in vaccine demand that exceeds the currently available supply resulting in global calls for next generation cholera vaccines. DuoChol is a novel, thermostable, low-cost oral cholera vaccine capsule currently in development which has the potential to introduce programmatic benefits and efficiencies in cholera vaccination campaigns.
Objectives
This qualitative study aimed to identify country-specific challenges in handling, distributing, and storing cholera vaccines and to assess the feasibility, acceptability, and policy implications of vaccine capsules compared to current products and practices in vaccination campaigns.
Methods
Using the World Health Organization's Vaccine Innovation Framework, consultations were conducted with 81 immunization programme stakeholders from Bangladesh, Ethiopia, Kenya, Mozambique and Tanzania.
Results
Key barriers to cholera vaccination include challenges in disbursing funds to subnational levels and the need for surged resources, such as additional health workers and cold chain equipment, during campaigns. Stakeholders discussed attributes of the novel vaccine such as improved thermostability and presentation which could reduce or eliminate the existing barriers.
Conclusions
The stakeholders highlighted that vaccine capsules are desirable for use in the general population as they have the potential to have many advantages over the current practice. However, for children who are not able to swallow the capsule, the currently available liquid oral cholera vaccine may be more desirable. To make an eventual informed decision about whether to recommend use of the vaccine capsule, national stakeholders requested the generation of evidence derived from pilot studies.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Spasenoska, D., Kahn, A.-L., Bouhenia, M., D'Cor, N. A., Lee, J.-S., Park, S. E., & Lynch, J. (2025). Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries. BMC Public Health, 25(1), 4147–4147.

MLA Style

Spasenoska, D, et al. “Uptake Likelihood Assessment of Oral Cholera Vaccine Capsules: Insights from Stakeholder Consultations in Five Countries.” BMC Public Health, vol. 25, no. 1, 2025, pp. 4147–47.

Chicago Style

Spasenoska, D, A-L Kahn, M Bouhenia, et al. 2025. “Uptake Likelihood Assessment of Oral Cholera Vaccine Capsules: Insights from Stakeholder Consultations in Five Countries.” BMC Public Health 25 (1): 4147–47.
Print